Health Industry

"Health Industry" Main

Latest Morning Briefing Stories

With Drug Costs In Crosshairs, Health Firms Gave Generously To Trump’s Inauguration

KFF Health News Original

Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump’s inauguration, which earned them entry into private events with the president and vice president.

California Presses Forward In Fight To Regulate Pharma

KFF Health News Original

Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.

Muerte por 1,000 recortes: cómo pueden los republicanos alterar su cobertura de salud

KFF Health News Original

Los peores enemigos de la Ley de Cuidado de Salud Asequible ahora están a cargo. Y están discutiendo cambios que podrían afectar a una más amplia red de planes de empleadores y a la cobertura del Medicare para los adultos mayores.

Drugmakers Help Turn Patients With Rare Diseases Into D.C. Lobbyists

KFF Health News Original

Amplifying the “patient voice,” those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.

Trump’s Effort To Lure Consumers To Exchanges Could Bring Skimpier Plans

KFF Health News Original

The changes proposed by the administration for the health law marketplaces in 2018 could increase customers’ out-of-pocket costs and reduce the amount they receive in premium tax credits.

Dispositivos que salvan vidas en los Estados Unidos se fabrican en México

KFF Health News Original

Casi todos los estadounidenses con marcapasos -y personas en todo el mundo- caminan portando partes fabricadas en Tijuana, México, en donde se ha creado una industria que podría estar en riesgo si la administración Trump cambia el juego del comercio global.

Senators Demand Answers About Possible Probe Of HHS Secretary Price

KFF Health News Original

Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.